Diastolic dysfunction and thin filament dysregulation resulting from excitation-contraction uncoupling in a mouse

Jennifer Davis1, Soichiro Yasuda, Nathan J Palpant

  • 1Department of Integrative Biology and Physiology, University of Minnesota Medical School, Minneapolis, MN 55455, USA.

Insights

A cardiac troponin I (cTnI) mutation (R193H) causes restrictive cardiomyopathy by increasing diastolic tone and impairing relaxation in heart cells. This leads to elevated end-diastolic pressure, mimicking clinical RCM symptoms.

Area of Science:

  • Cardiology
  • Molecular Biology
  • Genetics

Background:

  • Restrictive cardiomyopathy (RCM) is linked to mutations in cardiac troponin I (cTnI).
  • The genotype-to-phenotype relationship in RCM remains unclear.
  • Understanding the molecular mechanisms of RCM is crucial for developing targeted therapies.

Purpose of the Study:

  • To investigate the functional consequences of an RCM-linked cTnI mutation (R193H) in a cardiac-specific transgenic mouse model.
  • To elucidate the cellular and organ-level mechanisms by which the R193H mutation contributes to diastolic dysfunction.
  • To determine if the R193H mutation directly causes elevated end-diastolic pressure (EDP) independent of altered cardiac morphology.

Main Methods:

  • Generation of cardiac-specific transgenic (Tg) mice expressing the R193H missense mutation in cTnI.
  • In vivo assessment of cardiac function, including end-diastolic pressure (EDP).
  • In vitro analysis of isolated adult cardiac myocytes using a carbon microfiber-based assay to measure passive tension, Ca(2+) sensitivity, and relaxation dynamics.

Main Results:

  • R193H Tg mouse hearts exhibited smaller size and significantly elevated EDP.
  • Isolated R193H Tg myocytes showed increased passive tension and Ca(2+)-independent diastolic tone.
  • Impaired myocyte relaxation and Ca(2+) decay uncoupling were observed, alongside blunted Ca(2+) transient amplitude and hypercontractility.

Conclusions:

  • The R193H cTnI mutation directly induces elevated EDP through a myocyte-intrinsic loss of compliance, independent of Ca(2+) cycling or cardiac morphology.
  • Impaired relaxation and elevated EDP in R193H Tg myocytes recapitulate the severe diastolic dysfunction seen in RCM patients.
  • This study identifies a specific molecular mechanism linking cTnI mutations to RCM pathogenesis.

Related Concept Videos

Cardiomyopathy IV: Restrictive Cardiomyopathy01:29

Cardiomyopathy IV: Restrictive Cardiomyopathy

Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
Cardiomyopathy I: Introduction and Classification01:25

Cardiomyopathy I: Introduction and Classification

Cardiomyopathy, or CMP, is a group of diseases affecting the myocardial structure, impairing its ability to pump blood effectively. This condition can lead to arrhythmias, heart failure, or sudden cardiac death.Cardiomyopathies are classified into primary and secondary categories:Primary Cardiomyopathy refers to conditions involving only the heart muscle that are often idiopathic (of unknown cause) or genetic. They primarily affect the myocardium without the involvement of other systemic...